Cervical Cancer (12 Products)
Cervical cancer is the second most common and the fifth most deadly cancer in women. Approximately 80% of cervical cancers occur in developing countries which makes emerging economies such as China a major target market for pharmaceutical companies in the cervical cancer sector. The following expert reports enable buyers to examine the essential issues: supply and demand, forecasts, drug development and discovery, licensing, SWOT analyses, key industry players and more. This is the place for the
inside track on market entry opportunities, growth strategies, buyer solutions and potential industry alliances in the area of cervical cancer drug development.
About Cervical Cancer Diagnostic Tests
Cervical cancer diagnostic tests are used to identify the presence of the precancerous or cancerous lesions in the cervix of a woman. These tests include an initial...
EUR 2342USD 2,500GBP 1,658
Global Cervical Cancer Epidemiology and Patient Flow Analysis - 2015
The author announced the results of its Cervical Cancer patient population study in a new report ‘Global Cervical Cancer Epidemiology and Patient Flow Analysis - 2015’. The report provides insights...
EUR 1124USD 1,200GBP 796
Cervical Cancer Pipeline Highlights - 2015
The latest report Cervical Cancer Pipeline Highlights – 2015, provides most up-to-date information on key pipeline molecules in the global Cervical Cancer market. It covers emerging therapies for Cervical...
EUR 628USD 670GBP 444
Cervical cancer is a global health problem and is the third most common cancer in women worldwide. Approximately 85% of the cases occur in women living in developing countries. The majority of invasive...
EUR 175USD 194GBP 120
Cervical cancer is the third and fourth most common cause of cancer incidence and mortality among women across the world. Though there has been a decline in cervical cancer mortality rates in the previous...
EUR 1686USD 1,800GBP 1,194
China's demand for Cervical Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's...
EUR 3746USD 4,000GBP 2,653
Global Cervical Cancer Pipeline Capsule - 2013
Fore Pharma’s latest report ‘Global Cervical Cancer Pipeline Capsule – 2013’ provides up-to-date information on key Research and Development (R&D) activities in the global cervical cancer market. It...
EUR 646USD 690GBP 458
Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format These reports are prepared by the senior market...
EUR 932USD 995GBP 660
Cervical Cancer Global Clinical Trials Review, H2, 2011
GlobalData's clinical trial report, “Cervical Cancer Global Clinical Trials Review, H2, 2011" provides data on the Cervical Cancer clinical...
EUR 937USD 1,000GBP 663
2011 O.U.S. Markets For External Radiation Therapy
2011 O U S Markets For External Radiation Therapy is a comprehensive market intelligence solution designed for senior executives who are looking for: - High quality, granular, deeply segmented data...
EUR 3653USD 3,900GBP 2,587
2011 Global Markets for External Radiation Therapy
2011 Global Markets for External Radiation Therapy is a comprehensive market intelligence solution designed for senior executives who are looking for: - High quality, granular, deeply segmented data...
EUR 6088USD 6,500GBP 4,312
2011 U.S. Markets for External Radiation Therapy
2011 U S Markets for External Radiation Therapy is a comprehensive market intelligence solution designed for senior executives who are looking for: - High quality, granular, deeply segmented data -...
EUR 3653USD 3,900GBP 2,587